Advances for the Treatment of Lower Extremity Arterial Disease Associated with Diabetes Mellitus

Overview

Journal Front Mol Biosci

Specialty Biology

Date 2022 Sep 5

PMID 36060247

Authors

Yang Pan

Yuting Luo

Jing Hong

Huacheng He

Lu Dai

Hong Zhu

Jiang Wu

Affiliations

Soon will be listed here.

Abstract

Lower extremity arterial disease (LEAD) is a major vascular complication of diabetes. Vascular endothelial cells dysfunction can exacerbate local ischemia, leading to a significant increase in amputation, disability, and even mortality in patients with diabetes combined with LEAD. Therefore, it is of great clinical importance to explore proper and effective treatments. Conventional treatments of diabetic LEAD include lifestyle management, medication, open surgery, endovascular treatment, and amputation. As interdisciplinary research emerges, regenerative medicine strategies have provided new insights to treat chronic limb threatening ischemia (CLTI). Therapeutic angiogenesis strategies, such as delivering growth factors, stem cells, drugs to ischemic tissues, have also been proposed to treat LEAD by fundamentally stimulating multidimensional vascular regeneration. Recent years have seen the rapid growth of tissue engineering technology; tissue-engineered biomaterials have been used to study the treatment of LEAD, such as encapsulation of growth factors and drugs in hydrogel to facilitate the restoration of blood perfusion in ischemic tissues of animals. The primary purpose of this review is to introduce treatments and novel biomaterials development in LEAD. Firstly, the pathogenesis of LEAD is briefly described. Secondly, conventional therapies and therapeutic angiogenesis strategies of LEAD are discussed. Finally, recent research advances and future perspectives on biomaterials in LEAD are proposed.

References

Pan T, Liu H, Fang Y, Wei Z, Gu S, Fang G . Predictors of responders to mononuclear stem cell-based therapeutic angiogenesis for no-option critical limb ischemia. Stem Cell Res Ther. 2019; 10(1):15. PMC: 6329149. DOI: 10.1186/s13287-018-1117-5. View

Kim P, Yim H, Choi Y, Kang B, Kim J, Kwon S . Injectable multifunctional microgel encapsulating outgrowth endothelial cells and growth factors for enhanced neovascularization. J Control Release. 2014; 187:1-13. DOI: 10.1016/j.jconrel.2014.05.010. View

Papavassiliou V, Walker S, Bolia A, Fishwick G, London N . Techniques for the endovascular management of complications following lower limb percutaneous transluminal angioplasty. Eur J Vasc Endovasc Surg. 2003; 25(2):125-30. DOI: 10.1053/ejvs.2002.1822. View

Nakamura S, Ishihara M, Takikawa M, Kishimoto S, Isoda S, Fujita M . Attenuation of limb loss in an experimentally induced hindlimb ischemic model by fibroblast growth factor-2/fragmin/protamine microparticles as a delivery system. Tissue Eng Part A. 2012; 18(21-22):2239-47. PMC: 3482845. DOI: 10.1089/ten.TEA.2011.0741. View

Jia X, Qi Y, Zheng R, Lin L, Hu C, Zhu Y . Discordance of Apolipoprotein B, Non-HDL-Cholesterol, and LDL-Cholesterol Predicts Risk of Increased Arterial Stiffness and Elevated Carotid Intima-Media Thickness in Middle-Aged and Elderly Chinese Adults. Front Cardiovasc Med. 2022; 9:906396. PMC: 9157542. DOI: 10.3389/fcvm.2022.906396. View

Peeters Weem S, Teraa M, de Borst G, Verhaar M, Moll F . Bone Marrow derived Cell Therapy in Critical Limb Ischemia: A Meta-analysis of Randomized Placebo Controlled Trials. Eur J Vasc Endovasc Surg. 2015; 50(6):775-83. DOI: 10.1016/j.ejvs.2015.08.018. View

Jayakumar R, Prabaharan M, Nair S, Tamura H . Novel chitin and chitosan nanofibers in biomedical applications. Biotechnol Adv. 2009; 28(1):142-50. DOI: 10.1016/j.biotechadv.2009.11.001. View

Moon S, Kim J, Park S, Lee H, Do J, Chung H . A system for treating ischemic disease using human embryonic stem cell-derived endothelial cells without direct incorporation. Biomaterials. 2011; 32(27):6445-55. DOI: 10.1016/j.biomaterials.2011.05.026. View

Zhou J, Zhao Y, Wang J, Zhang S, Liu Z, Zhen M . Therapeutic angiogenesis using basic fibroblast growth factor in combination with a collagen matrix in chronic hindlimb ischemia. ScientificWorldJournal. 2012; 2012:652794. PMC: 3362026. DOI: 10.1100/2012/652794. View

10.

Kalantari K, Afifi A, Jahangirian H, Webster T . Biomedical applications of chitosan electrospun nanofibers as a green polymer - Review. Carbohydr Polym. 2019; 207:588-600. DOI: 10.1016/j.carbpol.2018.12.011. View

11.

Jonason T, Bergstrom R . Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality. Acta Med Scand. 1987; 221(3):253-60. View

12.

Wang J, Cui W, Ye J, Ji S, Zhao X, Zhan L . A cellular delivery system fabricated with autologous BMSCs and collagen scaffold enhances angiogenesis and perfusion in ischemic hind limb. J Biomed Mater Res A. 2012; 100(6):1438-47. DOI: 10.1002/jbm.a.34081. View

13.

Lin C, Anseth K . PEG hydrogels for the controlled release of biomolecules in regenerative medicine. Pharm Res. 2008; 26(3):631-43. PMC: 5892412. DOI: 10.1007/s11095-008-9801-2. View

14.

Wang R, Yao X, Li T, Li X, Jin M, Ni Y . Reversible Thermoresponsive Hydrogel Fabricated from Natural Biopolymer for the Improvement of Critical Limb Ischemia by Controlling Release of Stem Cells. Adv Healthc Mater. 2019; 8(20):e1900967. DOI: 10.1002/adhm.201900967. View

15.

Chappell J, Song J, Burke C, Klibanov A, Price R . Targeted delivery of nanoparticles bearing fibroblast growth factor-2 by ultrasonic microbubble destruction for therapeutic arteriogenesis. Small. 2008; 4(10):1769-77. PMC: 2716217. DOI: 10.1002/smll.200800806. View

16.

Kamei M, Saunders W, Bayless K, Dye L, Davis G, Weinstein B . Endothelial tubes assemble from intracellular vacuoles in vivo. Nature. 2006; 442(7101):453-6. DOI: 10.1038/nature04923. View

17.

Li R, Pang Z, He H, Lee S, Qin J, Wu J . Drug depot-anchoring hydrogel: A self-assembling scaffold for localized drug release and enhanced stem cell differentiation. J Control Release. 2017; 261:234-245. DOI: 10.1016/j.jconrel.2017.07.008. View

18.

Xing Z, Zhao C, Liu H, Fan Y . Endothelial Progenitor Cell-Derived Extracellular Vesicles: A Novel Candidate for Regenerative Medicine and Disease Treatment. Adv Healthc Mater. 2020; 9(12):e2000255. DOI: 10.1002/adhm.202000255. View

19.

McQueen M, Hawken S, Wang X, Ounpuu S, Sniderman A, Probstfield J . Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet. 2008; 372(9634):224-33. DOI: 10.1016/S0140-6736(08)61076-4. View

20.

Lee N, Bayaraa O, Zechu Z, Kim H . Biomaterials-assisted spheroid engineering for regenerative therapy. BMB Rep. 2021; 54(7):356-367. PMC: 8328824. View